Barbara Bigelow recently met with Senator Elizabeth Warren to talk about clinical trials and to express her concerns about cancer research being held up by the government shut down and the current political environment.
Here's More Advocacy in Action
How to Advocate for a Population that you are not Part of (Dana Deighton)
Dana Deighton will present How to Advocate for a Population You Are Not A Part Of. July 23, 1:00 pm ET, 10:00 am PT. Dana Deighton is an accomplished communications leader with over 30 years of experience in corporate marketing and communications, publishing, partner/project/program management, and patient advocacy. Currently, she is the Director of Communications…
Writing and Sharing Your Story: A Conversation with Wenora Johnson
Many advocates want to publish their personal stories, but often aren’t always sure where to begin. My advice is to start with your “why.” Ask yourself: Why do I want to tell this story? Is it to educate others, encourage early screening, influence research, or help another patient feel less alone? Your purpose will help…
A perspective on cancer advocacy from another discipline
“Ending Dementia Stigma could Change its Trajectory: Cancer’s History Shows Why” highlights the impact of cancer advocates from the perspective of the slow progress in the world of dementia research. This article by Saskia Sivananthan recently appeared in The Conversation. “Cancer did not change its stigma entirely because it became curable. It became curable faster…
The patient and public involvement toolkit (Cancer Research UK)
Cancer Research UK (CRUK) has prepared a toolkit to assist researchers in patient and public involvement (PPI), noting that PPI can improve the quality and relevance of the research, and help articulate its benefits for cancer patients and members of the public.
2025: The Year in Cancer Review (from Cancer Today)
This is an excellent summary of many of the top cancer stories of 2025 from the staff at Cancer Today.
